The Impact of Local Anesthetic Dilution on Possible Blinding for Nerve Blocks

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

April 1, 2026

Conditions
Healthy
Interventions
DRUG

Ropivacaine 0,1%

"The study uses ropivacaine for nerve blocks, starting at 0.1% concentration and capped at 0.5% for safety. Concentration adjustments are made based on each participant's response 60 minutes post-injection:~* Increase by 0.025% if pain reduction is \<50%~* Increase by 0.025% if reduction is 50-75% without sensory/motor block~* Decrease by 0.025% if reduction is 50-75% with sensory/motor block~* Decrease by 0.025% if reduction is \>75%. Pain is assessed using a Numerical Rating Scale. The study employs Dixon's up-and-down method for five cycles to determine the optimal concentration for effective pain relief without significant numbness or weakness."

OTHER

NaCl (placebo)

0.9 % NaCl solution (saline) injection

Trial Locations (2)

8008

NOT_YET_RECRUITING

Balgrist University Hospital, Zurich

RECRUITING

Balgrist University Hospital, Zurich

All Listed Sponsors
lead

Balgrist University Hospital

OTHER